- Home
- RGC vs MRCC Comparison
RGC vs MRCC Comparison
Compare RGC & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- MRCC
- Stock Information
- Founded
- RGC 2014
- MRCC 2011
- Country
- RGC Hong Kong
- MRCC United States
- Employees
- RGC N/A
- MRCC N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- MRCC Investment Managers
- Sector
- RGC Health Care
- MRCC Finance
- Exchange
- RGC Nasdaq
- MRCC Nasdaq
- Market Cap
- RGC 171.1M
- MRCC 174.8M
- IPO Year
- RGC 2021
- MRCC 2012
- Fundamental
- Price
- RGC $5.56
- MRCC $8.04
- Analyst Decision
- RGC
- MRCC Strong Buy
- Analyst Count
- RGC 0
- MRCC 1
- Target Price
- RGC N/A
- MRCC $9.00
- AVG Volume (30 Days)
- RGC 28.0K
- MRCC 44.4K
- Earning Date
- RGC 10-25-2024
- MRCC 11-06-2024
- Dividend Yield
- RGC N/A
- MRCC 12.94%
- EPS Growth
- RGC N/A
- MRCC 194.63
- EPS
- RGC N/A
- MRCC 0.36
- Revenue
- RGC N/A
- MRCC $61,955,000.00
- Revenue This Year
- RGC N/A
- MRCC N/A
- Revenue Next Year
- RGC N/A
- MRCC N/A
- P/E Ratio
- RGC N/A
- MRCC $21.47
- Revenue Growth
- RGC N/A
- MRCC N/A
- 52 Week Low
- RGC $3.03
- MRCC $6.69
- 52 Week High
- RGC $32.44
- MRCC $8.14
- Technical
- Relative Strength Index (RSI)
- RGC 39.52
- MRCC 52.73
- Support Level
- RGC $5.05
- MRCC $7.73
- Resistance Level
- RGC $6.57
- MRCC $8.11
- Average True Range (ATR)
- RGC 0.72
- MRCC 0.13
- MACD
- RGC -0.22
- MRCC -0.01
- Stochastic Oscillator
- RGC 13.99
- MRCC 42.05
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.